(Circulation. 2001;104:358.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
From the Ludwig Institute for Cancer Research, Stockholm Branch (K.A., G.v.E., X.L., A.P., B.O., U.E.); the Department of Physiology and Pharmacology, Section of Integrative Cardiovascular Physiology (P.T.) and Microbiology and Tumorbiology Center, Section of Angiogenesis Research (Y.C.), Karolinska Institutet, Stockholm; and the Department of Medical Biochemistry, University of Göteborg, Göteborg (S.G.-M., M.P., C.B.), Sweden; and the Molecular/Cancer Biology Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland (K.A.).
Correspondence to Ulf Eriksson, PhD, Ludwig Institute for Cancer Research, Stockholm Branch, Box 240, S-171 77 Stockholm, Sweden. E-mail ueri{at}licr.ki.se
Background Vascular endothelial growth factors (VEGFs) and their receptors are essential regulators of vasculogenesis and angiogenesis in both embryos and adults. One of the factors with a still unknown physiological function is VEGF-B, which is expressed in many tissues, including the heart.
Methods and Results Mice carrying a targeted deletion in the VEGF-B gene were developed. In VEGF-B-/- animals, no gross abnormalities were observed in organs that normally show high expression of VEGF-B, such as the heart, muscle, and kidney. Analysis of heart function by ECG showed that adult VEGF-B-/- mice have an atrial conduction abnormality characterized by a prolonged PQ interval. VEGF- or basic fibroblast growth factorinduced corneal angiogenesis was similar in normal and VEGF-B-/- mice.
Conclusions VEGF-B seems to be required for normal heart function in adult animals but is not required for proper development of the cardiovascular system either during development or for angiogenesis in adults.
Key Words: growth substances angiogenesis electrocardiography atrium conduction
This article has been cited by other articles:
![]() |
R. J. Tomanek, Y. Ishii, J. S. Holifield, C. L. Sjogren, H. K. Hansen, and T. Mikawa VEGF Family Members Regulate Myocardial Tubulogenesis and Coronary Artery Formation in the Embryo Circ. Res., April 14, 2006; 98(7): 947 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Malik, M. E. Baldwin, F. Peale, G. Fuh, W.-C. Liang, H. Lowman, G. Meng, N. Ferrara, and H.-P. Gerber Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice Blood, January 15, 2006; 107(2): 550 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Mould, S. A. Greco, M. M. Cahill, I. D. Tonks, D. Bellomo, C. Patterson, A. Zournazi, A. Nash, P. Scotney, N. K. Hayward, et al. Transgenic Overexpression of Vascular Endothelial Growth Factor-B Isoforms by Endothelial Cells Potentiates Postnatal Vessel Growth In Vivo and In Vitro Circ. Res., September 16, 2005; 97(6): e60 - e70. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen The biology of vascular endothelial growth factors Cardiovasc Res, February 15, 2005; 65(3): 550 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hiratsuka, Y. Kataoka, K. Nakao, K. Nakamura, S. Morikawa, S. Tanaka, M. Katsuki, Y. Maru, and M. Shibuya Vascular Endothelial Growth Factor A (VEGF-A) Is Involved in Guidance of VEGF Receptor-Positive Cells to the Anterior Portion of Early Embryos Mol. Cell. Biol., January 1, 2005; 25(1): 355 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cao, A. Eriksson, H. Kubo, K. Alitalo, Y. Cao, and J. Thyberg Comparative Evaluation of FGF-2-, VEGF-A-, and VEGF-C-Induced Angiogenesis, Lymphangiogenesis, Vascular Fenestrations, and Permeability Circ. Res., March 19, 2004; 94(5): 664 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ponten, X. Li, P. Thoren, K. Aase, T. Sjoblom, A. Ostman, and U. Eriksson Transgenic Overexpression of Platelet-Derived Growth Factor-C in the Mouse Heart Induces Cardiac Fibrosis, Hypertrophy, and Dilated Cardiomyopathy Am. J. Pathol., August 1, 2003; 163(2): 673 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-s. Yoon and D. W. Losordo All in the Family: VEGF-B Joins the Ranks of Proangiogenic Cytokines Circ. Res., July 25, 2003; 93(2): 87 - 90. [Full Text] [PDF] |
||||
![]() |
A. Luttun and P. Carmeliet De novo vasculogenesis in the heart Cardiovasc Res, May 1, 2003; 58(2): 378 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Wanstall, A. Gambino, T. K Jeffery, M. M Cahill, D. Bellomo, N. K Hayward, and G. F Kay Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension Cardiovasc Res, August 1, 2002; 55(2): 361 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jussila and K. Alitalo Vascular Growth Factors and Lymphangiogenesis Physiol Rev, July 1, 2002; 82(3): 673 - 700. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |